Company Filing History:
Years Active: 2012-2018
Title: The Innovative Contributions of Daniel Edward Vaughn
Introduction: Daniel Edward Vaughn, based in Encinitas, California, is an accomplished inventor who has made significant strides in the field of biochemistry and medical innovations. With a total of four patents to his name, Vaughn's work focuses on developing stable formulations that enhance the efficacy of insulin treatment for diabetic patients.
Latest Patents: Vaughn’s recent patents reflect his dedication to improving healthcare outcomes. One of his latest innovations includes the "Stable formulations of a hyaluronan-degrading enzyme." This patent describes compositions that are stable formulations of a hyaluronan-degrading enzyme, as well as stable co-formulations of fast-acting insulin and a hyaluronan-degrading enzyme, which includes the recombinant human PH20 (rHuPH20). Another notable patent is the "Method for control of post-prandial glucose." This invention outlines a method for managing post-prandial glucose levels in diabetic individuals through the administration of a fast-acting insulin analog and a hyaluronidase degrading enzyme, notably administered between 15 minutes before and 30 minutes after meals.
Career Highlights: Vaughn is currently associated with Halozyme, Inc., a company known for its innovative approaches in drug development. His work there has significantly contributed to advancements in treatments for diabetes and related conditions.
Collaborations: Throughout his career, Vaughn has collaborated with notable individuals such as Gregory Ian Frost and Igor Bilinsky. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and furthers innovative research in their respective fields.
Conclusion: Daniel Edward Vaughn stands out as a prominent figure in the realm of medical inventions. With his four patents, he continues to drive innovation that not only seeks to improve the stability and efficacy of insulin treatments but also leads to better health management for diabetic patients. His work underscores the importance of innovation and collaboration in advancing medical science.